Artificial pancreas is the latest cutting-edge solution to end the ordeal of diabetics who require daily dosages of insulin. The device developed by UK-based Cambridge University researchers comprises a pager-sized pump and a high-tech sensor to replenish insulin levels. The device operates with the glucose sensor, which is implanted under the skin to measure the blood glucose level on a minute-to minute basis. The tracked readings are then transferred to a remote computer and based on the readings the required amount of insulin to be administered for the given condition is calculated. The information is then transmitted to the glucose pump, which is worn either on the patient’s belt or arm and contains a supply of insulin, and the desired amount of insulin is then injected into the body via tube placed under the skin.
In another development, a team led by Dr Paul Stoddart, a researcher at Swinburne University of Technology has designed a new system that can be used to constantly monitor blood sugar levels. The research funded by the Diabetes Australia Research Trust and ASX listed company BioPharmica, has developed a new innovative wristwatch-sized device in an optic fiber probe. According to Dr Paul Stoddart, the device will help to monitor the blood glucose levels more precisely and less invasively by gently pressing beneath the skin’s surface and save a diabetic from the several painful pricks associated with the traditional prick test approach.
Meanwhile, a new study conducted by India's National Dairy Research Institute revealed that a daily supplement of probiotic yoghurt may prove beneficial in reducing the risk of diabetes. The experiment performed on male albino Wistar rats fed on fructose solution and yoghurt showed improved levels of markers for type-2 diabetes in comparison to rats fed on normal diet and those fed on fructose solution in addition to normal diet.
Powered by Qumana